Monoclonal antibodies (mAbs) drugs development

Genovior provides custom IND-enabling CMC services in monoclonal antibodies (mAbs) drugs development with the team of experienced scientists and proprietary development platform, and using advanced equipment, supporting our clients in development, analysis, and GMP manufacturing of biopharmaceuticals from pre-clinical to commercial production.

Our services are listed as below:
  • Mammalian cell Line development
  • Cell culture process development
  • Protein purification process development
  • Analysis method research & development
  • Scale up study to pilot and commercial manufacturing